Cor Vasa 2022, 64(4):478-481 | DOI: 10.33678/cor.2021.134

(Pheochromocytoma as a rare cause of fatal heart failure)

Matej Strýčeka, Jiří Seinera, b, Jan Štrosa, Pavol Tomašova, b, Rostislav Polášeka, b
a Krajská nemocnice Liberec, a.s., Liberec
b Fakulta zdravotních studií, Technická univerzita v Liberci, Liberec

Pheochromocytoma is a tumor that arises from chromaffin cells of the adrenal medulla. Together with sympathetic paragangliomas, these are relatively rare catecholamine-secreting tumors. They are one of the less common causes of secondary hypertension. The clinical presentation of pheochromocytoma is very variable. The classic triad of symptoms in patients with a pheochromocytoma consists of paroxysmal episodic headache, sweating, and palpitations. In our case report, we present a patient in whom pheochromocytoma manifested primarily as a fatal heart failure.

Keywords: Acute heart failure, Cardiogenic shock, Pheochromocytoma, Stressed cardiomyopathy

Received: November 3, 2021; Revised: November 5, 2021; Accepted: November 23, 2021; Published: September 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Strýček M, Seiner J, Štros J, Tomašov P, Polášek R. (Pheochromocytoma as a rare cause of fatal heart failure). Cor Vasa. 2022;64(4):478-481. doi: 10.33678/cor.2021.134.
Download citation

References

  1. Lenders JWM, Kerstens MN, Amar L, et al. Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension. J Hypertens 2020;38:1443-1456. Go to original source... Go to PubMed...
  2. Pacak K, Linehan WM, Eisenhofer G, et al. Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 2001;134:315-329. Go to original source... Go to PubMed...
  3. Beard CM, Sheps SG, Kurland LT, et al. Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc 1983;58:802-804.
  4. Hekimian G, Kharcha F, Bréchot N, et al. Extracorporeal membrane oxygenation for pheochromocytoma-induced cardiogenic shock. Ann Intensive Care 2016;6:117. Go to original source... Go to PubMed...
  5. Sutton MG, Sheps SG, Lie JT. Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series. Mayo Clin Proc 1981;56:354-360.
  6. Amar L, Eisenhofer G. Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging. Clin Endocrinol (Oxf) 2015;83:298-302. Go to original source... Go to PubMed...
  7. Jacques AE, Sahdev A, Sandrasagara M, et al. Adrenal phaeochromocytoma: Correlation of MRI appearances with histology and function. Eur Radiol 2008;18:2885-2892. Go to original source... Go to PubMed...
  8. Motta-Ramirez GA, Remer EM, Herts BR, et al. Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. Am J Roentgenol 2005;185:684-688. Go to original source... Go to PubMed...
  9. Čtvrtlík F, Heřman M, Študent V, et al. Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 2009;69:243-252. Go to original source... Go to PubMed...
  10. Gianni M, Dentali F, Grandi AM, et al. Apical ballooning syndrome or takotsubo cardiomyopathy: a systematic review. Eur Heart J 2006;27:1523-1529. Go to original source... Go to PubMed...
  11. Nef HM, Möllmann H, Kostin S, et al. Tako-Tsubo cardiomyopathy: intraindividual structural analysis in the acute phase and after functional recovery. Eur Heart J 2007;28:2456-2464. Go to original source... Go to PubMed...
  12. Y-Hassan S. Clinical Features and Outcome of Pheochromocytoma-Induced Takotsubo Syndrome: Analysis of 80 Published Cases. Am J Cardiol 2016;117:1836-1844. Go to original source... Go to PubMed...
  13. Santos JRU, Brofferio A, Viana B, Pacak K. Catecholamine- -Induced Cardiomyopathy in Pheochromocytoma: How to Manage a Rare Complication in a Rare Disease? Horm Metab Res 2019;51:458-469. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.